GILD

Gilead Sciences, Inc. News Headlines

$103.53
*  
0.66
0.63%
Get GILD Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales? - Analyst Blog
1/28/2015 5:50:00 AM - Investopedia


Do You Believe Me Now?
1/27/2015 10:59:00 AM - Seeking Alpha


Celgene: Could You Be More Like Gilead, Please?
1/27/2015 7:47:00 AM - Seeking Alpha


Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog
1/27/2015 6:55:00 AM - Investopedia


Gilead Expands Hepatitis C Generic Licensing Deal To Include Pan-Genotypic Agent
1/26/2015 1:12:00 AM - RTT News


3 Attractive Biotech Picks For 2015
1/23/2015 9:44:00 AM - Seeking Alpha


What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry
1/23/2015 7:30:00 AM - Seeking Alpha


2014 Portfolio Review: Year One Of My DGI Journey, Part I
1/22/2015 6:29:00 PM - Seeking Alpha


Cramer's Lightning Round - No Panic Over Gilead (1/20/15)
1/21/2015 3:32:00 PM - Seeking Alpha


Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary
1/21/2015 1:00:00 PM - Investopedia


Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog
1/21/2015 11:02:00 AM - Investopedia


50% Upside For Gilead In 2015
1/21/2015 9:15:00 AM - Seeking Alpha


AbbVie Provides Outlook For 2015: Let's Analyze It
1/21/2015 2:24:00 AM - Seeking Alpha


Gilead Is Still A Buy, But Expect Continued Compression Of The P/E Ratio.
1/20/2015 2:50:00 PM - Seeking Alpha


Gilead, Abbvie Price War May Reach Fever Pitch In Europe
1/20/2015 10:32:00 AM - Seeking Alpha


The Week That Was: Healthcare Outlook Remains Excellent
1/20/2015 9:44:00 AM - Seeking Alpha


AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog
1/19/2015 6:35:00 AM - Investopedia


Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
1/16/2015 4:00:00 PM - Seeking Alpha


Gilead: A Bullish Update
1/16/2015 2:08:00 PM - Seeking Alpha


How To Play Gilead In 2015: It's Going To Be A Bumpy Ride
1/16/2015 1:45:00 PM - Seeking Alpha


5 Stock Picks For 2015
1/16/2015 10:18:00 AM - Seeking Alpha


Gilead Sciences' Recent Trading Pattern Is Much To Do About Nothing
1/16/2015 8:13:00 AM - Seeking Alpha


Amgen Will Deliver In 2015
1/15/2015 8:22:00 AM - Seeking Alpha


India Rejects Gilead Patent Bid
1/14/2015 9:35:00 PM - Dow Jones Business News


India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment -- WSJ Blogs
1/14/2015 9:31:00 PM - Dow Jones Business News